Clinical Trials Logo

Abscess clinical trials

View clinical trials related to Abscess.

Filter by:

NCT ID: NCT00925665 Completed - Odontogenic Abscess Clinical Trials

Intubation of Patients With Odontogenic Abcesses

Start date: January 2009
Phase: N/A
Study type: Observational

This study is a comparison of two techniques for endotracheal intubation (Glidescope versus Macintosh) in patients with odontogenic abscesses.

NCT ID: NCT00895089 Completed - Liver Abscess Clinical Trials

Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess

Start date: May 2009
Phase: Phase 4
Study type: Interventional

This clinical trial compares the use of moxifloxacin versus ceftriaxone in the treatment of primary pyogenic liver abscess. The trial will include nonpregnant adults presenting with primary liver abscess based on clinical diagnosis and computed tomography. The trial aims to determine whether the use of moxifloxacin can effectively treat primary pyogenic liver abscess and shorten hospitalization. This regimen has the additional benefit of avoiding nephrotoxic agents, such as aminoglycosides, used frequently in treatment of pyogenic liver abscess. Development of antibiotic resistance to colonized bacteria in the gastrointestinal tract will also be evaluated using stool cultures.

NCT ID: NCT00829686 Completed - Abscess Clinical Trials

Trial of Antibiotic Treatment for Skin Abscess in Patients at Risk for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection

Start date: June 2008
Phase: N/A
Study type: Interventional

Patients will be enrolled in a multi-center study (WHMC and BAMC) to prospectively evaluate outcome after treatment for an uncomplicated skin abscess. All patients will receive incision and drainage and wound cultures. Patients will then be randomized to 1)no antibiotic or 2) bactrim DS (800/160) two tablets PO BID x 7 days. This is the dose recommended for treating skin and soft tissue infections. (Ellis et al. Current Opinion in Infectious Diseases. 18(6):496-501, December 2005) Patients will then return to the ER on days 3 and 7 for wound repacking and evaluation. The primary outcome is clinical cure of abscess at 7 days after incision and drainage and recurrence rates within 30 days of treatment. Patients who are not improving at the following visit will then be treated with additional antibiotics or admission if needed. Data will be analyzed both by initial randomization and intention to treat. This serves as the pilot for the full placebo controlled randomized trial.

NCT ID: NCT00822692 Completed - Abscess Clinical Trials

Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection

Start date: July 2008
Phase: N/A
Study type: Interventional

Patients will be enrolled in a multi-center study (Wilford Hall Medical Center and Brooke Army Medical Center) to prospectively evaluate outcome after treatment for an uncomplicated skin abscess.

NCT ID: NCT00746109 Completed - Wounds Clinical Trials

Study of Wound Packing After Superficial Skin Abscess Drainage

Start date: September 2008
Phase: Phase 4
Study type: Interventional

Superficial skin and soft tissue abscess are frequently managed by opening them up with a procedure called "incision and drainage". It is routine practice in the United States to place packing material inside the abscess cavity after opening them up, in order to promote better wound healing and limit abscess recurrence. However, this practice has never been systematically studied or proven to decrease complications or improve healing. Patients with wound packing usually return to the emergency room or practice setting for multiple "wound checks" and dressing/packing changes which lead to missed days from work or school and utilization of healthcare resources. This procedure can often be painful and may even require conscious sedation (and the risks entailed) especially in children. With rates of superficial skin and soft tissue abscesses on the rise, and emergency room resources being stretched, it is important to determine whether packing wounds is necessary or even advantageous to patients. This study is the first to systematically evaluate the efficacy of wound packing after superficial skin or soft tissue abscess incision and drainage in children. The investigators will be evaluating wound healing, complications, recurrence and pain associated with packing both short and long term. In addition, the investigators will also be evaluating the utility of bedside point-of-care ultrasound use in predicting the presence of pus inside the abscess cavity. This test may be useful to determine whether incision and drainage is necessary for an individual who has a skin infection that is suspicious for an abscess.

NCT ID: NCT00737269 Completed - Clinical trials for Surgical Wound Infection

A Complicated Skin and Soft-tissue Infection Patient Registry

Start date: June 2008
Phase: Phase 4
Study type: Observational

The purpose of this registry is to better understand (1) complicated skin and soft-tissue infections requiring hospitalization, and (2) clinical and economic outcomes in hospitalized patients receiving intravenous antibiotic therapy.

NCT ID: NCT00691600 Completed - Abscess Clinical Trials

Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage

Start date: December 2007
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare rates of cure of abscesses with and without antibiotic treatment after incision and drainage. The purpose of this study is to compare successful rates of cure of abscesses less than 5 cm with antibiotic (oral TMP/SMX) versus non-antibiotic treatment after incision and drainage.

NCT ID: NCT00679302 Completed - Clinical trials for Skin Diseases, Infectious

Utility of Trimethoprim-sulfamethoxazole Use in Skin Abscess Management

Start date: July 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if antibiotics are required in the management of skin abscess following incision and drainage.

NCT ID: NCT00646958 Completed - Abscess Clinical Trials

Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections

Start date: December 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy, safety and tolerability of RX-1741, an oxazolidinone, versus linezolid, another oxazolidinone, in the treatment of uncomplicated skin and skin structure infections

NCT ID: NCT00641992 Completed - Clinical trials for Amebic Liver Abscess

Prognosis of Failure Treatment of Amebic Liver Abscess

Start date: May 1999
Phase: N/A
Study type: Observational

Amebic liver abscess is the most frequent extra-intestinal form of the amoebiasis; actually the factors for predicting failure in the medical treatment are not clear. We conducted trial for determining the clinical value of paraclinical factor in this issue.